FdaApplication
ANDA 217377
Identifiers
- fda_app_no: ANDA217377
Properties
| Property | Value |
|---|---|
| applicant_name | TWI PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2023-03-01 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DILTIAZEM HYDROCHLORIDE | DILTIAZEM HYDROCHLORIDE | 120MG | CAPSULE, EXTENDED RELEASE;ORAL |
| DILTIAZEM HYDROCHLORIDE | DILTIAZEM HYDROCHLORIDE | 90MG | CAPSULE, EXTENDED RELEASE;ORAL |
| DILTIAZEM HYDROCHLORIDE | DILTIAZEM HYDROCHLORIDE | 60MG | CAPSULE, EXTENDED RELEASE;ORAL |
3 products